IRVINE, Calif.–(BUSINESS WIRE)–MindFrame Inc. today
announces the issuance of U.S. Patent No. 8,088,140, bringing the total number
of patents awarded for its breakthrough thrombectomy technology to three. The
previous two patents, U.S. Patent Nos. 8,066,757 and 8,070,791, demonstrate
MindFrames commitment to developing innovative devices that deliver
outstanding outcomes for ischemic stroke therapy, in which rapid flow
restoration and clot retrieval is essential to prevent irreversible
deterioration of brain function in millions of patients suffering from acute
ischemic stroke.
“We are proud that our achievements in revolutionary
proprietary technology are being recognized,” says Ken Charhut, president and
CEO of MindFrame Inc. “Our global mission is to continue leading technology
development with more ischemic stroke solutions for our clinicians that allow
successful procedural and clinical outcomes for their patients.”
The MindFrame Therapy Solutions technology portfolio was
recently expanded to include the MindFrame Capture LP 4-mm diameter and
multiple shorter-length–sized low profile devices. The MindFrame Capture LP is
the first and only device that can be deployed through smaller microcatheters
to improve navigation through tortuous vessels. MindFrame LP devices provide
clinicians with unprecedented access to thrombus aspiration locally and
proximally as a result of the reduced microcatheter size. In addition, the
devices offer improved tensile strength and kink resistance for device
durability, as well as enhanced trackability for precise placement and control.
MindFrame Capture LP is not approved for sale in the United States.
About MindFrame Inc.
MindFrame Inc. is a pioneer in developing optimized technologies for patients
experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions
portfolio comprises some of the most advanced device design technology that
delivers exceptional rapid flow restoration and clot extraction intended to
help clinicians provide improved clinical outcomes for their patients. For more
information about the breakthrough MindFrame Capture LP state-of-the-art
technologies, visit www.MindFrameInc.com.
Posted by Sean Fenske, Editor-in-Chief, MDT